Feasibility study of adjuvant chemotherapy with carboplatin and nab-paclitaxel for resected NSCLC
Not Applicable
- Conditions
- resected NSCLC(stage II - IIIB)
- Registration Number
- JPRN-UMIN000011910
- Lead Sponsor
- Division of Respiratory Medicine, Department of Internal Medicine,Kobe University Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 21
Inclusion Criteria
Not provided
Exclusion Criteria
(1)The patient with infection (2)The patient with fever (equal to or more than 38 C) (3)The patient with heavy complication (4)The patient with active double-cancer (5)The patient with uncontrolled pleural effuson (6)The patient with a motor-palsy or figure of peripheral-nerve-disease (7)The patient with drug hypersensitivity (8)The patient with common use of NSAIDs (9)The expectant mother, the woman who has a lactating-woman and the possibility of the pregnancy (10)The patient judged as unsuitable by the doctor
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method safety
- Secondary Outcome Measures
Name Time Method 1.Chemotherapy compliance in the four cycles 2.2-years disease free survival